Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
d-Amphetamine Transdermal System (d-ATS), amphetamine (Transdermal amphetamine)
print preview
bookmark
share with colleague
General Information
Company
Hisamitsu Pharmaceutical Co. Inc.
Description
Transdermal amphetamine patch
Molecular Target
Dopamine transporter
Mechanism of Action
Dopamine and norepinephrine reuptake inhibitor
Latest Stage of Development
Phase II
Indication
Attention deficit hyperactivity disorder (ADHD)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information